PRESS RELEASE published on 01/18/2024 at 13:00, 2 years 1 month ago Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer Envision Pharma Group appoints Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team. With her extensive experience in the life sciences industry, Carolyn is set to play a crucial role in securing and retaining top talent to support Envision's growth. Her strategic vision aligns seamlessly with the company's priorities, and her exceptional leadership experience will be integral to advancing Envision's strategic goals. Envision Pharma Group Talent Acquisition Life Sciences Industry Carolyn Bartholdson Chief People Officer
PRESS RELEASE published on 01/16/2024 at 13:00, 2 years 1 month ago Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) to lead the organization's IMC division of experts in medical strategy, medical communications, publications planning and delivery, and patient engagement, delivering smarter, faster outcomes for life sciences clients. With a wealth of experience in the global life sciences industry, Alice brings strategic expertise, knowledge, and insight to drive the company's vision forward and meet client needs. She joins from IPG Health, where she served as EVP, Managing Director, Client Solutions, APAC, and played a pivotal role in business growth and operational excellence. Her commitment to best practices and standards in medical communications is evident in her various leadership roles. Envision Pharma Group, founded in 2001, is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies. Learn more at www.envisionpharmagroup.com. Envision Pharma Group Alice Choi Medical Communications Life Sciences Clients Global Technology-enabled Strategic Solutions
PRESS RELEASE published on 11/15/2023 at 13:00, 2 years 3 months ago Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
PRESS RELEASE published on 06/15/2023 at 13:00, 2 years 8 months ago OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
PRESS RELEASE published on 05/09/2023 at 13:00, 2 years 9 months ago Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
PRESS RELEASE published on 05/04/2023 at 13:00, 2 years 9 months ago Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer
PRESS RELEASE published on 05/03/2023 at 15:05, 2 years 9 months ago Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics
PRESS RELEASE published on 05/01/2023 at 13:00, 2 years 9 months ago Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights
PRESS RELEASE published on 03/30/2023 at 13:00, 2 years 10 months ago Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
PRESS RELEASE published on 03/29/2023 at 17:45, 2 years 10 months ago Envision Pharma Group Appoints Life Science Industry Expert James Streeter as New President of Technology, CTO
Published on 02/18/2026 at 15:15, 3 hours 28 minutes ago Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now
Published on 02/18/2026 at 15:00, 3 hours 43 minutes ago Jaguar Health Announces a Special One-time Stock Dividend
Published on 02/18/2026 at 14:25, 4 hours 18 minutes ago Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular
Published on 02/18/2026 at 14:00, 4 hours 43 minutes ago Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico
Published on 02/18/2026 at 14:00, 4 hours 43 minutes ago Datametrex Receives $1M Order from Fortune 500 Client
Published on 02/18/2026 at 18:21, 22 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/18/2026 at 18:00, 43 minutes ago E-PANGO : Décision du Tribunal administratif de Paris en date du 16 février 2026
Published on 02/18/2026 at 17:58, 45 minutes ago 2CRSi SA: 2CRSi initiates, within the ÆTHER Infrastructure consortium, an exclusive negotiation for the establishment of a strategic industrial site dedicated to AI Gigafactories
Published on 02/18/2026 at 17:58, 45 minutes ago 2CRSi SA: 2CRSi initie, au sein du consortium ÆTHER Infrastructure, une négociation exclusive pour l’implantation d’un site industriel stratégique dédié aux AI Gigafactories
Published on 02/18/2026 at 15:50, 2 hours 53 minutes ago CGTN: Private economy: A key actor in advancing China's economic priorities in 2026 and beyond
Published on 02/18/2026 at 18:00, 43 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 janvier 2026
Published on 02/18/2026 at 18:00, 43 minutes ago Outstanding Shares and Voting Rights Statement at 31 January 2026
Published on 02/18/2026 at 13:45, 4 hours 58 minutes ago NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède